Dara-BCD for Rare MGRS

Clinical trial NCT06771180 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06771180
Sponsor: Peking University People's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Monoclonal Gammopathy of Renal Significance (MGRS)

Start date: 2025-01-15
Primary completion: 2025-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.